Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms.
about
Corticosterone primes the neuroinflammatory response to DFP in mice: potential animal model of Gulf War IllnessGlucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunctionPrevalence of and risk factors for severe cognitive and sleep symptoms in ME/CFS and MSDNA methylation modifications associated with chronic fatigue syndrome.Neuroendocrine and immune contributors to fatigueInfluence of the number and severity of somatic symptoms on the severity of depression and suicidality in community-dwelling elders.Prognostic significance of functional somatic symptoms in adolescence: a 15-year community-based follow-up study of adolescents with depression compared with healthy peers.Explanatory models of medically unexplained symptoms: a qualitative analysis of the literature.The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances.A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis.Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot studyThe subject, its biology, and the chronic recurrent cystitis.Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).Exercise Modifies the Gut Microbiota with Positive Health EffectsIncreased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)Heat shock proteins and chronic fatigue in primary Sjögren's syndrome.Programmed symptoms: disparate effects united by purpose.Psychological factors associated with development of TMD: the OPPERA prospective cohort study.Multivitamin mineral supplementation in patients with chronic fatigue syndrome.A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.Chondroitin sulfate disaccharides modified the structure and function of the murine gut microbiome under healthy and stressed conditions.Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome.The Immune System and the Role of Inflammation in Perinatal Depression.Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress.Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.Antipsychotic-like effect of minocycline in a rat model.Coping Strategies Used by Syrian Refugees in Jordan.Increased Root Canal Endotoxin Levels are Associated with Chronic Apical Periodontitis, Increased Oxidative and Nitrosative Stress, Major Depression, Severity of Depression, and a Lowered Quality of Life.Neuroprotective mechanism of losartan and its interaction with nimesulide against chronic fatigue stress.Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.Liquiritigenin induces mitochondria-mediated apoptosis via cytochrome c release and caspases activation in HeLa Cells.Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patientsOxidative Stress is a Convincing Contributor to Idiopathic Chronic Fatigue
P2860
Q23914342-37B7BA50-0826-41E7-B3DA-D0AF3172EB63Q27024383-7B9B550F-8E30-466F-ABC3-154628CB1860Q33816383-A939E336-CB02-4459-8019-0DBE97DA1BE5Q34027879-5DF80042-AA52-47DA-B222-E2910FCC8A72Q34103068-FA123B7D-EB5A-4897-99EC-8D86256176D8Q34231839-FC1E4FC1-7FD1-4F4E-B138-5C1946369253Q34354480-CC2EE758-C233-41BE-8937-A8664D7326A9Q34870096-F4E39372-2201-47BE-AD4D-C9BE4B82D0ADQ35162025-9A67BF18-BBA8-4818-A814-2E7AAF5AA92BQ35204426-97CAA289-A52A-463A-A06F-F79983EDB071Q35873043-9E230633-6FBC-4FC8-AFA3-4BB80A7C5D4EQ35896707-49D6A700-53D7-47FF-94C1-4F8674116384Q36169154-CB509017-EC46-4FEA-B5A1-02353CE5FF57Q36288936-433F833D-8B5A-431E-A7B0-C0AFC37910A5Q36327600-F74D063B-B194-49B2-8E33-648D89E32FAEQ36516368-2F766D9E-9F18-4242-99A0-C620CBC4E180Q36719483-52B6DDD9-EFEE-4A07-A2D0-AA3F56AB1C81Q37204042-C009C8C2-F082-418C-AC22-14894ECA6845Q37374565-F8A74556-CA74-4416-A944-3576AAA21E87Q37534474-28766EEA-2B0F-40F0-8867-F8E54EA18DF8Q38020430-75345CFF-6FDB-4C0A-970E-ED64B3ACAE26Q38322773-7A9F619F-29A1-4BE8-9EBB-C74E15C01F3AQ38654292-904E270A-9FB6-4E62-9101-F5D65DEF98ECQ38875536-3BDC2492-96CC-4C76-9477-7184642F6BE9Q38901677-9673AE78-88DE-4555-AFE3-E0D59BE0D998Q41442524-064BD0BD-496F-4622-9BC6-F90137EDD864Q42735475-F625C4EC-5707-4486-BE16-37B1071BBB8CQ43015622-F881594C-9DB1-4AB4-BC3D-3C3FC438F353Q47560244-765911E4-0CA3-4831-B94C-6DC2BAD30B52Q47891845-F362717F-880D-4202-B1F5-75AC0E578FD6Q48103115-98DDFE4A-0A94-4981-9663-7DAC2176FAF4Q48638595-ED629E89-9233-46E0-BD30-892DD1E8EB12Q53310500-10367ECA-EF44-4DA7-A07F-61A42C13D211Q57834176-29B79D43-93ED-4AEF-B4F4-62B0D066696AQ58701188-BD7CAAF6-3F08-4636-8572-42F6D8FEA9A1
P2860
Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inflammatory and oxidative and ...... on and psychosomatic symptoms.
@ast
Inflammatory and oxidative and ...... on and psychosomatic symptoms.
@en
Inflammatory and oxidative and ...... on and psychosomatic symptoms.
@nl
type
label
Inflammatory and oxidative and ...... on and psychosomatic symptoms.
@ast
Inflammatory and oxidative and ...... on and psychosomatic symptoms.
@en
Inflammatory and oxidative and ...... on and psychosomatic symptoms.
@nl
prefLabel
Inflammatory and oxidative and ...... on and psychosomatic symptoms.
@ast
Inflammatory and oxidative and ...... on and psychosomatic symptoms.
@en
Inflammatory and oxidative and ...... on and psychosomatic symptoms.
@nl
P1476
Inflammatory and oxidative and ...... on and psychosomatic symptoms.
@en
P356
10.1097/YCO.0B013E32831A4728
P50
P577
2009-01-01T00:00:00Z